EE309 Cost-Effectiveness of Mavacamten for the Treatment of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy in the Netherlands
Abstract
Authors
L. Buisman M. Treur M. Verkaik G. Van De Wetering L.M. Pronk M. Pompen M. Hurst